NCT05138991Active, not recruiting
Reproducibility and Accuracy of a Portable System for Early Detection of Cardiac Dysfunction in Childhood Cancer Survivors
Assessment of the Reproducibility and Accuracy of a Portable System for Early Detection of Cardiac Dysfunction in Childhood Cancer Survivors
Source: ClinicalTrials.gov · Last updated 23 Sept 2025
Brief summary (registry, in English)
The clinical trial compares the reproducibility and accuracy of cardiac tonometry-based portable systems that may detect early cardiac dysfunction (SphygmoCor® Xcel and Oscar 2™ ambulatory blood pressure monitor) at home and in the clinic to currently available screening tests for heart failure including echocardiogram (echo) and cardiovascular magnetic resonance (CMR). The SphygmoCor® Xcel and Oscar 2™ systems may help detect cardiac dysfunction earlier than other available screening tests because it can be self-administered outside of the clinic. This study aims to test the accuracy and practicality of these devices in the clinic setting and at home.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 149 (actual)
- First submitted
- 22 Nov 2021
- Start date
- 22 Jun 2022
- Primary completion date
- 16 Jul 2026
- Lead sponsor
- City of Hope Medical Center
- Diseases
- Childhood cancers
- NCT number
- NCT05138991
What you commit to
- Study type: Interventional
- Participants enrolled: 149
- From 22 Jun 2022 to the primary completion date, 16 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participants cannot be actively receiving cancer-directed therapy.
- Standard exclusion criteria for CMR imaging will be incorporated, and these include: implanted pacemaker or defibrillator, insulin pump, cochlear implant, central nervous system aneurismal clips, implanted neural stimulator, ocular foreign body (metal), other implanted medical devices (e.g.: drug infusion ports).
Who the study is looking for
- Previously enrolled in IRB# 14154.
- Able to understand and sign the study specific informed consent form (ICF).
Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| City of Hope Medical Center Coordinator of this site? Confirm its status | Duarte | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.